David Arkowitz

Insider Reports History

Location
Burlington, MA
Signature
/s/ Marc Banjak, Attorney-in-fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by David Arkowitz:

Company Role Class Num Shares Value Price $ Report Date Ownership
Flexion Therapeutics Inc Chief Financial Officer Common Stock 220,719 $1,876,112 $8.50 10 May 2021 Direct
Seres Therapeutics, Inc. Chief Financial Officer Common Stock 182,442 $197,037 $1.08 16 Feb 2024 Direct
iBio, Inc. Director Common Stock 18,382 $49,999 $2.72 10 Jan 2025 Direct
Seres Therapeutics, Inc. Chief Financial Officer Restricted Stock Units 31,875 $43,031 $1.35 15 Feb 2024 Direct
KINETA, INC./DE Director Common Stock 0 $0 $0.3300 30 Jun 2025 Direct
Seres Therapeutics, Inc. Chief Financial Officer Stock Option (Right to Buy) 287,905 14 Feb 2024 Direct
F-star Therapeutics, Inc. Director Stock Option 20,000 17 Jun 2022 Direct
iBio, Inc. Director Stock Option (right to buy) 13,500 20 Nov 2025 Direct
F-star Therapeutics, Inc. Director Common Stock 0 $7.12 08 Mar 2023 Direct
F-star Therapeutics, Inc. Director Warrant (right to buy) 0 20 Nov 2020 Direct
KINETA, INC./DE Director Stock Option (Right to Buy) 0 30 Jun 2025 Direct

Insider Reports Filed by David Arkowitz

Symbol Company Period Transactions Value $ Form Type Role Filing Time
IBIO iBio, Inc. 20 Nov 2025 1 $0 4 Director 24 Nov 2025, 16:05
KANT KINETA, INC./DE 30 Jun 2025 3 $0 4 Director 02 Jul 2025, 16:21
KANT KINETA, INC./DE 23 Jun 2025 4 +$6,414 4 Director 25 Jun 2025, 21:49
IBIO iBio, Inc. 10 Jan 2025 1 +$49,999 4 Director 13 Jan 2025, 16:32
IBIO iBio, Inc. 21 Nov 2024 1 $0 4 Director 25 Nov 2024, 16:31
IBIO iBio, Inc. 21 Nov 2024 0 $0 3 Director 25 Nov 2024, 16:30
KANT KINETA, INC./DE 04 Sep 2024 1 $0 4 Director 05 Sep 2024, 16:18
MCRB Seres Therapeutics, Inc. 14 Feb 2024 6 -$4,254 4 Chief Financial Officer 16 Feb 2024, 21:13
MCRB Seres Therapeutics, Inc. 27 Oct 2023 4 -$5,489 4 Chief Financial Officer 31 Oct 2023, 21:39
MCRB Seres Therapeutics, Inc. 27 Apr 2023 1 $0 4 Chief Financial Officer 01 May 2023, 16:43
KANT KINETA, INC./DE 12 Apr 2023 2 $0 4 Director 14 Apr 2023, 16:06
MCRB Seres Therapeutics, Inc. 03 Feb 2023 2 $0 4 Chief Financial Officer 07 Feb 2023, 16:44
MCRB Seres Therapeutics, Inc. 05 Jul 2022 1 +$200,000 4 Chief Financial Officer 06 Jul 2022, 19:23
/report/000120919122038712-arkowitz-david-2022-06-17 F-star Therapeutics, Inc. 17 Jun 2022 1 $0 4 Director 22 Jun 2022, 17:06
MCRB Seres Therapeutics, Inc. 15 Jun 2022 3 $0 4 Chief Financial Officer 31 Oct 2022, 18:05
MCRB Seres Therapeutics, Inc. 04 Feb 2022 1 $0 4 Executive Vice President, Chief Financial Officer and Head of Business Development 08 Feb 2022, 20:30
/report/000120919121038552-arkowitz-david-2021-06-04 F-star Therapeutics, Inc. 04 Jun 2021 1 $0 4 Director 07 Jun 2021, 16:03
KANT YUMANITY THERAPEUTICS, INC. 02 Jun 2021 1 $0 4 Director 04 Jun 2021, 16:05
MCRB Seres Therapeutics, Inc. 01 Jun 2021 2 $0 4 Chief Financial Officer 01 Jun 2021, 21:25
MCRB Seres Therapeutics, Inc. 01 Jun 2021 0 $0 3 Chief Financial Officer 01 Jun 2021, 21:14
/report/000120919121032103-arkowitz-david-2021-05-10 Flexion Therapeutics Inc 10 May 2021 1 -$16,116 4 Chief Financial Officer 12 May 2021, 17:06
/report/000089924323007654-arkowitz-david-2020-11-20 F-star Therapeutics, Inc. 20 Nov 2020 10 -$59,708 4 Director 09 Mar 2023, 08:10